Purchase Order 75N94022P00497
Award Date
7/7/22
Potential Completion Date
1/30/23
Potential Value
$477K
Funding Federal Agency
National Institute of Diabetes and Digestive and Kidney Diseases
Contracting Federal Agency
National Institute of Child Health and Human Development
Awardee
Bruker Biospin Corp
Ultimate Awardee
Bruker Corporation
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Billerica, MA 01821, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $1,526,289.00 firm fixed-price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse to Bruker Biospin Corp, a for-profit manufacturer, to provide an AVANCE NEO 500 MHz wide-bore nuclear magnetic resonance (NMR) spectrometer and associated hardware and software. The contract was awarded on July 10, 2019 with a completion date of October 14, 2020. This award was not set aside for a specific business...
The U.S. Department of Health and Human Services, National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $2,855,935.00 firm-fixed-price contract to Bruker Biospin Corp, a for-profit manufacturer, to provide five Avance Neo consoles for Bruker NMR spectrometers, a Q-band pulse 300 W amplifier for a Q-band pulsed EPR spectrometer, and two cryoplatforms for Bruker NMR spectrometers. This award supports upgrading the NMR and EPR...
The National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases awarded a $587,061 firm fixed price purchase order to Bruker Biospin Corp. to acquire an Avance Neo 700 MHz NMR console compatible with an existing 700 MHz spectrometer located at NIH's campus in Bethesda, Maryland. The solicitation sought quotes for the NMR equipment upgrade by September 5, 2023, with delivery and installation within six to nine months of award. Evaluation factors included...
This federal contract award to Bruker Biospin Corp, a subsidiary of Bruker Corporation, is for the procurement of scientific instrumentation and equipment. The $6,500 firm-fixed-price purchase order, awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), was for the delivery of unspecified Bruker products by December 29, 2017. The award did not utilize any set-aside designations, indicating Bruker Biospin Corp competed openly for this contract. As a leading...
This federal contract award, valued at $649,508.00, was issued by the National Institute of Child Health and Human Development (NICHD) to Bruker Biospin Corp, a subsidiary of the Bruker Corporation. The contract is for the procurement of an AVANCE NEO 600 MHz wide-band nuclear magnetic resonance (NMR) spectrometer console. This specialized scientific instrument will support critical research and testing programs at NICHD, a civilian agency under the U.S. Department of Health and Human...
This federal contract award, valued at $440,500.00, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Bruker Biospin Corp, a manufacturer of scientific instruments. The award is for the purchase of an AVANCE III HD 600 console, as described in the associated quote. The end user is Gideon Clore, and the contract does not have a set-aside designation. Bruker Biospin Corp is known to provide nuclear magnetic resonance spectrometers, upgrades, maintenance,...
This federal contract award was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency under the U.S. Department of Health and Human Services, to Bruker Biospin Corp, a subsidiary of the Bruker Corporation. The $203,775.00 firm-fixed-price purchase order was awarded on September 10, 2016 with a completion date of September 18, 2017. Bruker Biospin Corp is a manufacturer of scientific instruments and provides specialized equipment, maintenance,...
This is a $216,140.00 firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Bruker Biospin Corp, a wholly-owned subsidiary of Bruker Corporation. The contract is for the delivery of a MARIUS CLORE IN 5/B1-301ER 4118HVCF5L FLEXLINE CRYOGEN-FREE VTSYSTEM, which is a specialized nuclear magnetic resonance (NMR) spectrometer system. The award does not utilize any set-aside designations. Bruker Biospin Corp is an established...
This federal contract award was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Bruker Biospin Corp, a subsidiary of the Bruker Corporation. The $322,000.00 firm fixed-price purchase order is for the delivery of scientific instrumentation, primarily nuclear magnetic resonance (NMR) spectrometers, magnetic resonance imaging (MRI) systems, and electron spin resonance (EPR) spectrometers. This award was not set aside and was competed...
This firm-fixed-price purchase order was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Bruker Biospin Corp. to provide annual service and maintenance for a Bruker Ascend 400 MHz nuclear magnetic resonance (NMR) spectrometer system with an Avance Neo Nanobay. The contract has a ceiling value of $68,484.50 and a period of performance through August 8, 2028. This award is not associated with any set-aside...